HIV Alert: Novel Strategies and Agents for HIV Management

Listen to downloadable audio from a series of live Webinars by Daniel R. Kuritzkes, MD, and Paul E. Sax, MD, in which potential future HIV treatment strategies—including long-acting ART, dual-therapy regimens, and investigational agents—are discussed and audience questions on this subject are addressed.
Format: Audio (.mp3)
File Size: 35.40 MB
Released: November 13, 2017

Listen to downloadable audio from a series of live Webinars by Daniel R. Kuritzkes, MD, and Paul E. Sax, MD, in which potential future HIV treatment strategies—including long-acting ART, dual-therapy regimens, and investigational agents—are discussed and audience questions on this subject are addressed. (45 minutes)

Daniel R. Kuritzkes, MD, has disclosed that he has received consulting fees from Gilead Sciences, GlaxoSmithKline, Janssen, Merck, and ViiV and funds for research support from Abbott, Gilead Sciences, and Merck.

Paul E. Sax, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Janssen, and Merck and funds for research support from Bristol-Myers Squibb, Gilead Sciences, and GlaxoSmithKline/ViiV.

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

Post-hoc analysis of DAWNING study at CROI 2019 supports use of dolutegravir-based ART in the presence of NRTI RAMs as reported by Clinical Care Options

Released: March 13, 2019

Latest data on phase III FLAIR study of long-acting cabotegravir plus rilpivirine for maintenance ART from CROI 2019 as reported by Clinical Care Options

Released: March 11, 2019

Post hoc analysis of weight gain in HPTN 077 study of cabotegravir vs placebo in HIV-uninfected persons from CROI 2019 as reported by Clinical Care Options

Released: March 11, 2019

Week 48 data from Study 380-1474 of BIC/FTC/TAF as maintenance ART in children and adolescents from CROI 2019 as reported by Clinical Care Options

Released: March 11, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?